Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C, Lindström S, Malmer B, Wiklund F, Augustsson-Bälter K, Adami HO, Stattin P, Nilsson M, Dahlman-Wright K, Gustafsson JA, Grönberg H.
Thellenberg-Karlsson C, et al. Among authors: gronberg h.
Clin Cancer Res. 2006 Mar 15;12(6):1936-41. doi: 10.1158/1078-0432.CCR-05-0269.
Clin Cancer Res. 2006.
PMID: 16551880